Apellis Pharmaceuticals, Inc.
APLSDelisted May 14, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001492422
Apellis Pharmaceuticals, Inc. was delisted on May 14, 2026; its insiders filed their last Form 4 on May 14, 2026; 324 institutions reported holding it in 13F filings for Q1 2026, worth $5.56B in total; Soros Fund Management was the only superinvestor holding it.
Q1 2023 vs. Q4 2022
How the institutions holding Apellis Pharmaceuticals, Inc. changed between Q4 2022 and Q1 2023.
All holders in Q1 2023All holders in Q4 2022
| Measure | Q4 2022 | Of which not filed for Q1 2023 | Q1 2023 | Change |
|---|---|---|---|---|
| Holders | 244 | 3 | 282 | +41 |
| Shares | 100.5M | 87.8K | 110.4M | +9.95M (+9.9%) |
| Value | $5.20B | $4.56M | $7.28B | +$2.09B (+40.2%) |
3 institutions that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (68)
Institutions that held Apellis Pharmaceuticals, Inc. at the end of Q1 2023 but not at the end of Q4 2022.
Sold out (27)
Institutions that held Apellis Pharmaceuticals, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.
Not filed for Q1 2023 yet (3)
Institutions that held Apellis Pharmaceuticals, Inc. at the end of Q4 2022 and haven't filed a 13F for Q1 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2022 | Value, Q4 2022 |
|---|---|---|
| Comerica Bank | 66,230 | $3.44M |
| Regent Investment Management LLC | 21,309 | $1.10M |
| CoreCap Advisors, LLC | 300 | $15.5K |